Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd share price and stock overview

Sun Pharmaceutical Industries Ltd (NSE: SUNPHARMA, BSE: 524715) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE044A01036 and a face value of Rs 1. As of 12 August 2026, it trades at Rs (1,942.00) with a market capitalisation of Rs 468530.14 crore. Figures are live and subject to change.

Sun Pharmaceutical Industries Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
1,942.00 -2.40 (-0.12%) downArrowC
As on: 12-Aug-2026 , 01:46 AM
Market Cap(₹Cr) 468530.14
Book Value(₹Cr) 93.2373503
BSE Code : 524715 NSE Symbol : SUNPHARMA EPS(TTM) : 13.27 ISIN Demat : INE044A01036 P/E(TTM) : 147.16 Face Value(₹) : 1 Div & Yield % : 0.82

Today Market

Stock Performance

Today Market

Today's High

78,509.77

Todday's Low

78,048.26

Open at

78,509.77

Previous Close

78,542.44

Volumes

Avg Price

-388.19

Historical Performance

News

05 Aug 26
Sun Pharma's long-term bank facilities reaffirmed as ‘CRISIL AAA/Stable’ with watch status removed
Sun Pharmaceutical Industries Ltd announced that CRISIL Ratings Limited ("CRISIL") has removed the ‘Rating Watch with Developing Implications’ status and reaffirmed the rating assigned to the Company's long-term bank facilities at ‘CRISIL AAA/Stable’ (Reaffirmed; Removed from ‘Rating Watch with Developing Implications’), referencing a prior communication dated May 7, 2026, which initially detailed CRISIL’s reaffirmation of the ‘CRISIL AAA’ rating with the aforementioned watch status following an announcement on April 27, 2026; no other rating agencies or instruments are mentioned in the communication.
31 Jul 26
Sun Pharmaceutical Industries Ltd consolidated sales up 4.28% on year in Q2FY2026, net profit saw a marginal increase of 6.87%
Sun Pharmaceutical Industries Ltd share price ticked higher by 0.55% to Rs 2000.75 after the company's net profit grew slightly 6.
31 Jul 26
Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter
Net profit of Sun Pharmaceutical Industries rose 27.04% to Rs 2894.79 crore in the quarter ended June 2026 as against Rs 2278.
31 Jul 26
Sun Pharmaceutical Industries Ltd spurts 1.6%, rises for fifth straight session
Sun Pharmaceutical Industries Ltd gained for a fifth straight session today. The stock is quoting at Rs 2033.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
11-08-26 1939.00 1951.10 1928.60 1942.00 2125972 83745 4124775388.60 24471.70
10-08-26 1949.90 1965.00 1939.80 1944.40 1726946 94522 3366338556.60 24583.80
07-08-26 1955.00 1957.00 1925.10 1945.00 2425268 119502 4699863722.70 24570.65
06-08-26 1930.00 1965.90 1930.00 1951.00 1864891 154516 3644133858.50 24636.00
05-08-26 1967.80 1968.20 1934.00 1940.00 2152829 108744 4179279124.70 24624.65
04-08-26 1951.10 1965.00 1947.00 1964.00 1452888 61625 2843372131.20 24614.90
03-08-26 1983.20 1988.00 1935.20 1963.50 3972351 339336 7766580397.20 24774.30
31-07-26 2016.40 2046.90 1965.30 1990.50 4954449 185717 9927935717.40 24383.60
30-07-26 1993.10 2017.30 1988.00 2001.10 2224264 125242 4464460165.70 24317.15
29-07-26 1977.00 1992.70 1960.40 1989.90 2682295 106408 5305826340.40 24250.20
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

468530.14

PE Ratio

147.16

PB Ratio

20.94

Dividend Yield

0.82

ROE

12.73

ROCE

14.47

Book Value (₹)

93.2373503

Face Value (₹)

1

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 1047764374 43.67 1047752374 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 259355161 10.81 259355161 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1307119535 54.48 1307107535 14
Total ShareHolding for Promoter & Group 1307119535 54.48 1307107535 14
plus   Publice Share Holding
plus  Institution
Government(Central / State) 20877 0.00 20877 6
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1132894 0.05 1132894 7
Foreign Bank 1104 0.00 80 2
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 348687627 14.53 348679070 1078
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 168423279 7.02 168423279 34
Mutual Funds / UTI 308042226 12.84 308033314 49
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 54462860 2.27 54462860 57
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 880770867 36.71 880752374 1233
plus  Non Institution
Bodies Corporate 49066732 2.05 49014118 2409
Clearing Members 3633276 0.15 3633276 95
Directors & their Relatives 25155 0.00 25155 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 46000 0.00 46000 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6985511 0.29 6914749 21070
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 3511631 0.15 3509463 8625
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 26382947 1.10 26382947 32
Individuals holding nominal share capital up to Rs. 1 lakh 105080425 4.38 102322460 676443
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1647965 0.07 1647965 51
Others 9056120 0.38 9056120 6
Sub Total 211444568 8.81 208560379 708999
Total Public Shareholding 1092215435 45.52 1089312753 710232
Total of Promoter & Public ShareHolding 2399334970 100.00 2396420288 710246
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 2399334970 100.00 2396420288 710246

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales58,462.0452,578.4448,496.8543,885.6838,654.49
OPM (%)28.1027.4423.8821.8323.41
OP16,426.3614,429.9811,582.219,579.889,048.14
Other Income3,211.902,150.571,390.32634.521,075.47
PBIDT18,395.6416,558.8813,883.0012,109.866,752.41
INTEREST338.91231.36238.47172.00127.35
PBDT18,056.7316,327.5213,644.5311,937.866,625.06
PBT13,811.4013,074.2810,593.579,236.98-85.50
EO-1,307.48-677.85-494.32-171.45-4,566.82
PBT after EO15,118.8813,752.1311,087.899,408.434,481.32
TAXES3,554.362,772.031,439.45847.591,075.50
PAT11,479.4210,929.049,576.388,473.583,272.73
EPS47.8045.6039.9035.3013.60
Raw Material12.6412.2714.2417.7218.24
Power and Fuel1.391.431.571.891.82
Employee Cost19.5318.9719.4418.9018.89
Other Manufacturing Expenses0.000.001.301.281.44
Selling and Administration Expenses23.6623.2522.7521.6119.06
Miscellaneous Expenses3.082.922.962.352.09
Revenue (Growth %) 11.198.4210.5113.5315.39
PBIDT (Growth %)11.0919.2714.6479.3434.49
PAT (Growth %) 5.0414.1213.01158.9112.70
PBIDT (Margin %)31.4731.4928.6327.5917.47
PAT (Margin %) 19.6420.7919.7519.318.47

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 239.93239.93239.93239.93239.93239.93
Reserves Total 22130.8323660.3623454.4723508.4324348.0226698.54
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds22370.7623900.2923694.4023748.3624587.9526938.47
Secured Loans 0.000.000.000.000.005.41
Unsecured Loans 13604.7311947.0711226.917790.825074.047352.71
Total Debt13604.7311947.0711226.917790.825074.047358.12
Other Liabilities600.16799.841722.961105.451016.381342.13
Total Liabilities36575.6536647.2036644.2732644.6330678.3735638.72
APPLICATION OF FUNDS :
Gross Block 20680.5919199.8418251.7417744.6817194.9815812.29
Less : Accumulated Depreciation 13067.5011827.4110515.009033.017482.206143.50
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 7613.097372.437736.748711.679712.789668.79
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress899.391084.20766.11852.91828.641090.38
Producing Properties0.000.000.000.000.000.00
Investments 12951.5612410.1112429.9712613.2415548.8715537.20
Current Assets, Loans & Advances
Inventories 4302.273934.133423.623989.193403.743423.42
Sundry Debtors 10166.2311701.548834.167125.024245.166585.24
Cash and Bank Balance436.97911.05338.39421.28534.96360.98
Loans and Advances 1773.252233.982316.374708.001326.852329.44
Total Current Assets16678.7218780.7014912.5416243.499510.7112699.08
Less : Current Liabilities and Provisions
Current Liabilities 5340.126507.513811.447533.367524.566891.41
Provisions 1143.77723.76609.08809.502562.551204.66
Total Current Liabilities & Provisions6483.897231.274420.528342.8610087.118096.07
Net Current Assets10194.8311549.4310492.027900.63-576.404603.01
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets1277.962053.681889.791982.841389.471969.40
Deferred Tax Liability538.56886.04895.27950.451065.43631.95
Net Deferred Tax739.401167.64994.521032.39324.041337.45
Other Assets4177.383063.394224.911533.794840.443401.89
Total Assets36575.6536647.2036644.2732644.6330678.3735638.72
Contingent Liabilities1326.931990.94941.731087.401031.723083.04

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -4,870.85169.31473.95-3,836.13-5,230.18
Investing Activities -2,697.04-685.64-265.35-250.64-1,345.42
Net Cash Flow 68.47-9.25-83.82165.20-74.73
Operating Activities 7,636.36507.08-292.424,251.976,500.87

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
DSS
Dilip S Shanghvi
Chairman / Executive Director / M D / Promoter
Executive
Functional Directors
KWG
Kirti Wardhaman Ganorkar
Executive Director & MD
Exec.
VS
Vidhi Shanghvi
E D & Wholetime Director
Dir.
Independent Directors
PG
Pawan Goenka
Lead Independent Non Executive Director
Ind.
GD
Gautam Doshi
Independent Non Exe. Director
Ind.
RH
Rolf Hoffmann
Independent Non Exe. Director
Ind.
SB
Satyavati Berera
Independent Non Exe. Director
Ind.
AB
Andreas Busch
Independent Non Exe. Director
Ind.
Other Officials
ADS
AALOK DILIP SHANGHVI
ED / WTD / CFO / Promoter
Board
AAD
ANOOP ANJANIKUMAR DESHPANDE
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Sun Pharmaceutical Industries Ltd? −

Sun Pharmaceutical Industries Ltd trades on NSE under SUNPHARMA and on BSE under code 524715. The ISIN is INE044A01036 and the face value is Rs 1.

What is the share price of Sun Pharmaceutical Industries Ltd today? +

As of 12 August 2026, Sun Pharmaceutical Industries Ltd trades at Rs 1,942.00, a change of -2.40 (-0.12%) on the day. Prices are live and subject to change.

What is the market capitalisation of Sun Pharmaceutical Industries Ltd? +

As of 12 August 2026, Sun Pharmaceutical Industries Ltd has a market cap of about Rs 468530.14 crore. This figure is live and moves with the share price.

Is Sun Pharmaceutical Industries Ltd profitable? +

In March 2026, Sun Pharmaceutical Industries Ltd reported a profit after tax of Rs 11,479.42 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Sun Pharmaceutical Industries Ltd? +

: As of 12 August 2026, the PE (TTM) for Sun Pharmaceutical Industries Ltd is 147.16 and the price-to-book ratio is 20.94. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Sun Pharmaceutical Industries Ltd pay a dividend? +

As of 12 August 2026, the dividend yield for Sun Pharmaceutical Industries Ltd is 0.82%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Sun Pharmaceutical Industries Ltd? +

As of the latest disclosed pattern, promoters hold 54.48% of Sun Pharmaceutical Industries Ltd. Public shareholding is 45.52%, including mutual funds at 12.84% and foreign institutional investors at 14.53%.

What were the latest annual financials of Sun Pharmaceutical Industries Ltd? +

In March 2026, Sun Pharmaceutical Industries Ltd reported net sales of Rs 58,462.04 crore, revenue growth of 11.19%, and earnings per share of Rs 47.80.
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web